Drive Through Point of Care International Normalized Ratio Testing During the COVID-19 Pandemic

Open Access

|Dec 2020

Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Der Nigoghossian, C., Ageno, W., Madjid, M., Guo, Y., Tang, L. V., Hu, Y., Giri, J., Cushman, M., Quere, I., Dimakakos, E. P., Gibson, C. M., Lippi, G., Favaloro, E. J., … Lip, G. Y. H. (2020). COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up. Journal of the American College of Cardiology, 75(23), 2950–2973. DOI: 10.1016/j.jacc.2020.04.031
Open DOI Search in Google Scholar Back to article
Food and Drug Administration. (2016, February 17). Point of care prothrombin time/international normalized ratio devices for monitoring warfarin therapy; public workshop; request for comments [Public notice]. Federal Register. https://www.federalregister.gov/documents/2016/02/17/2016-03153/point-of-care-prothrombin-timeinternational-normalized-ratio-devices-for-monitoring-warfarin-therapy
Search in Google Scholar Back to article
Johnson, S. A. (2017, April 1). Point-of-care or clinical lab INR for anticoagulation monitoring: Which to believe? AACC. www.aacc.org/publications/cln/articles/2017/april/point-of-care-or-clinical-lab-inr-for-anticoagulation-monitoring-which-to-believe
Search in Google Scholar Back to article
Roche Diagnostics. (2020). CoaguChek® XS Pro System. Retrieved June 30, 2020, from diagnostics.roche.com/us/en/products/instruments/coaguchek-xs-pro.html#productSpecs
Search in Google Scholar Back to article